BACKGROUND: In the absence of positive cultures and draining sinuses, the diagnosis of periprosthetic joint infection (PJI) relies on laboratory values. It is unknown if administration of antibiotics within 2 weeks before diagnostic evaluations can affect these tests in patients with PJI. QUESTIONS/PURPOSES: The purpose of this study was to investigate the correlation of antibiotic administration with (1) fluctuations in the synovial fluid and serology laboratory values; and (2) sensitivity of the diagnostic tests in patients with late PJI (per Musculoskeletal Infection Society [MSIS] criteria). METHODS: Synovial white blood cell (WBC) count, polymorphonuclear neutrophil (PMN) percentage, and serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as well as culture results were investigated in 161 patients undergoing total knee arthroplasty with late PJI diagnosed with the MSIS criteria. Depending on whether presampling antibiotics were used, patients were divided in two groups (53 [33%] patients were on antibiotics). The median laboratory values and the false-negative rates were compared between the two groups. RESULTS: The median of all variables were lower in the antibiotic group compared with the other group: ESR (mm/hr): 70 versus 85, difference of medians (DOM) = 15 mm/hr, p = 0.018; CRP (mg/L): 72 versus 130, DOM = 58 mg/L, p = 0.038; synovial WBC (cells/μL): 29,170 versus 46,900, DOM = 17,730, p = 0.022; and synovial PMN%: 88.5% versus 92.5%, DOM = 4%, p = 0.012. Furthermore, using the MSIS cutoffs, the false-negative rates of several parameters were higher in the antibiotic group; ESR: 19.2% (nine of 47) versus 6.1% (six of 99) (relative risk, 3.1; 95% confidence interval [CI], 1.2-8.3; p = 0.020); CRP: 14.9% (seven of 47) versus 2.00% (two of 100) (relative risk, 7.4; 95% CI, 1.6-34.4); PMN%: 23.1% (12 of 52) versus 9.4% (10 of 106) (relative risk, 2.4; 95% CI, 1.1-5.2; p = 0.027). Patients in the antibiotic group also had higher rates of negative cultures: 26.4% (14 of 53) versus 12.9% (14 of 108) (relative risk, 2.0; 95% CI, 1.05-3.9; p = 0.046). CONCLUSIONS: It appears that premature antibiotic treatments are associated with lower medians of diagnostic laboratory values. Thus, and in line with the guideline recommendations of the American Academy of Orthopaedic Surgeons, patients with suspected late-PJI should not receive antibiotics until the diagnosis is reached or refuted. LEVEL OF EVIDENCE: Level III, diagnostic study.
BACKGROUND: In the absence of positive cultures and draining sinuses, the diagnosis of periprosthetic joint infection (PJI) relies on laboratory values. It is unknown if administration of antibiotics within 2 weeks before diagnostic evaluations can affect these tests in patients with PJI. QUESTIONS/PURPOSES: The purpose of this study was to investigate the correlation of antibiotic administration with (1) fluctuations in the synovial fluid and serology laboratory values; and (2) sensitivity of the diagnostic tests in patients with late PJI (per Musculoskeletal Infection Society [MSIS] criteria). METHODS: Synovial white blood cell (WBC) count, polymorphonuclear neutrophil (PMN) percentage, and serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as well as culture results were investigated in 161 patients undergoing total knee arthroplasty with late PJI diagnosed with the MSIS criteria. Depending on whether presampling antibiotics were used, patients were divided in two groups (53 [33%] patients were on antibiotics). The median laboratory values and the false-negative rates were compared between the two groups. RESULTS: The median of all variables were lower in the antibiotic group compared with the other group: ESR (mm/hr): 70 versus 85, difference of medians (DOM) = 15 mm/hr, p = 0.018; CRP (mg/L): 72 versus 130, DOM = 58 mg/L, p = 0.038; synovial WBC (cells/μL): 29,170 versus 46,900, DOM = 17,730, p = 0.022; and synovial PMN%: 88.5% versus 92.5%, DOM = 4%, p = 0.012. Furthermore, using the MSIS cutoffs, the false-negative rates of several parameters were higher in the antibiotic group; ESR: 19.2% (nine of 47) versus 6.1% (six of 99) (relative risk, 3.1; 95% confidence interval [CI], 1.2-8.3; p = 0.020); CRP: 14.9% (seven of 47) versus 2.00% (two of 100) (relative risk, 7.4; 95% CI, 1.6-34.4); PMN%: 23.1% (12 of 52) versus 9.4% (10 of 106) (relative risk, 2.4; 95% CI, 1.1-5.2; p = 0.027). Patients in the antibiotic group also had higher rates of negative cultures: 26.4% (14 of 53) versus 12.9% (14 of 108) (relative risk, 2.0; 95% CI, 1.05-3.9; p = 0.046). CONCLUSIONS: It appears that premature antibiotic treatments are associated with lower medians of diagnostic laboratory values. Thus, and in line with the guideline recommendations of the American Academy of Orthopaedic Surgeons, patients with suspected late-PJI should not receive antibiotics until the diagnosis is reached or refuted. LEVEL OF EVIDENCE: Level III, diagnostic study.
Authors: Davud Malekzadeh; Douglas R Osmon; Brian D Lahr; Arlen D Hanssen; Elie F Berbari Journal: Clin Orthop Relat Res Date: 2010-08 Impact factor: 4.176
Authors: Elie Ghanem; Javad Parvizi; John Clohisy; Stephen Burnett; Peter F Sharkey; Robert Barrack Journal: Clin Orthop Relat Res Date: 2007-08 Impact factor: 4.176
Authors: Elie Ghanem; Javad Parvizi; R Stephen J Burnett; Peter F Sharkey; Nahid Keshavarzi; Ajay Aggarwal; Robert L Barrack Journal: J Bone Joint Surg Am Date: 2008-08 Impact factor: 5.284
Authors: Javad Parvizi; Elie Ghanem; Peter Sharkey; Ajay Aggarwal; R Stephen J Burnett; Robert L Barrack Journal: Clin Orthop Relat Res Date: 2008-09-10 Impact factor: 4.176
Authors: R Stephen J Burnett; Ajay Aggarwal; Stephanie A Givens; J Thomas McClure; Patrick M Morgan; Robert L Barrack Journal: Clin Orthop Relat Res Date: 2009-08-11 Impact factor: 4.176
Authors: Craig Della Valle; Javad Parvizi; Thomas W Bauer; Paul E DiCesare; Richard Parker Evans; John Segreti; Mark Spangehl; William C Watters; Michael Keith; Charles M Turkelson; Janet L Wies; Patrick Sluka; Kristin Hitchcock Journal: J Bone Joint Surg Am Date: 2011-07-20 Impact factor: 5.284
Authors: Lluís Font-Vizcarra; Sebastián García; Juan C Martínez-Pastor; Josep M Sierra; Alex Soriano Journal: Clin Orthop Relat Res Date: 2010-02-17 Impact factor: 4.176
Authors: Elie F Berbari; Camelia Marculescu; Irene Sia; Brian D Lahr; Arlen D Hanssen; James M Steckelberg; Rachel Gullerud; Douglas R Osmon Journal: Clin Infect Dis Date: 2007-09-26 Impact factor: 9.079
Authors: Beverly L Hersh; Neel B Shah; Scott D Rothenberger; Jason P Zlotnicki; Brian A Klatt; Kenneth L Urish Journal: J Arthroplasty Date: 2019-06-28 Impact factor: 4.757
Authors: Jakrapun Pupaibool; Eric J Fulnecky; Robert L Swords; William W Sistrunk; Alastair D Haddow Journal: Int Orthop Date: 2016-10-07 Impact factor: 3.075
Authors: Tiziana Ascione; Giovanni Balato; Massimo Mariconda; Francesco Smeraglia; Andrea Baldini; Cristiano De Franco; Giuseppe Pandolfo; Roberta Siciliano; Pasquale Pagliano Journal: Clin Orthop Relat Res Date: 2021-09-01 Impact factor: 4.755